UCLA Health

Santa Monica, California 90404

1 studies enrolling now · 6 studies all time

What they study most

Adenocarcinoma - GEJ, Adenocarcinoma Gastric Stage IV With Metastases, Colorectal Neoplasm, Disc Degeneration;Cervical, Gout, HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Solid Tumor, Pancreatic Adenocarcinoma

Studies at this site

• Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout — Recruiting now
• DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) — Completed
• PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors — Completed
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma — Stopped early
• DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) — Completed
• The NanoStrand Clinical Study — Paused